Experts from Evidera’s Patient-Centered Research team will be presenting an ePoster at the 2nd Annual European Myeloma Network meeting titled, “Patient-Reported Experiences During and Following Treatment with Belantamab Mafodotin (Belamaf) for Relapsed/Refractory Multiple Myeloma (RRMM) in the DREAMM-2 Study.” Authors/presenters include: Eliason L, Correll J, Martin ML, Cardellino A, Opalinska J, Piontek T, Gorsh B, Sapra S, Popat R
